Mammography Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product Type (Full-field Digital Mammography, Film-screen Mammogram, Breast Tomosynthesis), By Technology (Digital v/s Analog), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region and Competition
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationMammography Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product Type (Full-field Digital Mammography, Film-screen Mammogram, Breast Tomosynthesis), By Technology (Digital v/s Analog), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region and Competition
| Forecast Period | 2024-2028 |
| Market Size (2022) | USD 2.43 Billion |
| CAGR (2023-2028) | 5.77% |
| Fastest Growing Segment | Digital |
| Largest Market | North America |
Market Overview
Key Market Drivers
Growing Burden of Breast Cancer
Technological Advancements in the Field of Breast Imaging
Increasing Mature Markets
Investment from Various Organizations in Breast Cancer Screening Campaigns
Key Market Challenges
Reduction in Reimbursement
Risk of Adverse Effects from Radiation Exposure
Key Market Trends
AI and Computer-Aided Detection (CAD)
Portable and Point-of-Care Mammography
Segmental Insights
Technology Insights
Based on technology, the market is segmented into digital and analog. The digital mammography segment is projected to capture a larger market share in the forecast period. Digital mammography, an advanced and specialized form of mammography, utilizes digital computers and receptors instead of X-ray films to examine breast tissue for cancer indicators. Technological advancements have spurred the emergence of digital mammography, offering advantages such as superior depiction of low-contrast objects, improved diagnostic image quality, and wider dynamic range. With a growing number of healthcare facilities adopting these modern systems, they also facilitate easy sharing of soft-copy image displays and soft-copy reading across devices. These factors have made digital mammography a favored choice among healthcare providers, while also ensuring significantly lower radiation exposure compared to conventional systems.
End User Insights
Based on the end user segment, hospitals and clinics dominated the end user segment in 2022, accounting for approximately 45.6% of the total revenue. The presence of mammography facilities within hospitals can have a positive impact on various factors, including hospital stay duration, healthcare cost, care quality, and emergency care availability. For example, in September 2019, Parkside Hospital in Wimbledon installed a 3Dimensions mammography system from Hologic, enabling high-resolution breast tomosynthesis.
Large hospitals typically have in-house mammography facilities, but the need for substantial investments, frequent maintenance, adequate space, and skilled professionals can pose entry barriers. This can burden hospitals in managing their medical imaging facilities. To alleviate this burden and expand the reach of their services, hospitals can establish partnerships with diagnostic centers to provide medical imaging facilities.
The diagnostic centers segment is expected to experience significant growth during the forecast period, driven by increased awareness about breast cancer. This has led to a surge in demand for mammography procedures for diagnosis, treatment planning, and prevention of breast cancer. The availability of advanced mammography services in diagnostic centers in developed and developing economies, such as the United States, Germany, the United Kingdom, Japan, China, and India, is anticipated to drive the overall segment's growth.
Regional Insights
Recent Developments
- Volpara Healthintroduced updated products for its integrated platform for personalized breastcare at the SBI/ACR Breast Imaging Symposium 2022 in May 2022. Volpara'sAI-driven breast software tools offer mammography quality and reporting,volumetric breast density measurements, and cancer risk assessment.
- ScreenPoint Medicalexpanded its presence in the United States and 30 other countries worldwidewith the launch of Transpara, an AI Breast Care system, in January 2022.
- In June 2021, iCADInc received CE Mark approval for ProFound AI® Version 3.0 for Digital BreastTomosynthesis (DBT) software. This latest version demonstrates up to a 10%improvement in specificity performance while maintaining an industry-leadinghigh sensitivity level.
- Hologic Inc obtainedproduct approval from the US Food and Drug Administration for their Genius AIDetection technology, a new deep learning-based software, in December 2020.This software, when used alongside the Genius 3D Mammography exam, aids in the earlydetection and identification of breast cancer.
- Therapixel receivedUS FDA approval for MammoScreen, a computer-assisted detection and diagnosissoftware, in March 2020. This software assists clinicians in identifyingrelevant findings when used with compatible full-field digital mammographysystems.
Key Market Players
- Hologic, Inc.
- Fujifilm Holdings Corporation
- Philips Healthcare
- Siemens Healthineers AG
- GE Healthcare
- Carestream Health, Inc.
- Konica Minolta Inc.
- Delphinus Medical Technologies, Inc.
- Analogic Corporation
- KUB Technologies, Inc.
| By Product Type | By Technology | By End User | By Region | |||
|
|
|
|
|
| |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy